Literature DB >> 12684748

Reversible nucleoside analogue-associated lactic acidosis despite a prolonged course.

P Delobel1, S Khatibi2, M Alvarez2, M Obadia2, E Bonnet2, P Massip2, B Marchou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12684748     DOI： 10.1007/s00134-003-1750-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.

Authors:  Y E Claessens; A Cariou; J D Chiche; G Dauriat; J F Dhainaut
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

2.  Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.

Authors:  K Brinkman
Journal:  Clin Infect Dis       Date:  2000-07-26       Impact factor: 9.079

Review 3.  Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

Authors:  K Brinkman; H J ter Hofstede; D M Burger; J A Smeitink; P P Koopmans
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

4.  Riboflavin to treat nucleoside analogue-induced lactic acidosis.

Authors:  B Fouty; F Frerman; R Reves
Journal:  Lancet       Date:  1998-07-25       Impact factor: 79.321

5.  Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.

Authors:  Vicente Falcó; Dolors Rodríguez; Esteban Ribera; Esteban Martínez; José Maria Miró; Pere Domingo; Ruth Diazaraque; José R Arribas; Juan J González-García; Francesc Montero; Lluis Sánchez; Albert Pahissa
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.